HomeCompareSYANY vs MRK

SYANY vs MRK: Dividend Comparison 2026

SYANY yields 3.11% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYANY wins by $493.10M in total portfolio value
10 years
SYANY
SYANY
● Live price
3.11%
Share price
$16.00
Annual div
$0.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$493.15M
Annual income
$464,434,417.90
Full SYANY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SYANY vs MRK

📍 SYANY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYANYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYANY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYANY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYANY
Annual income on $10K today (after 15% tax)
$264.06/yr
After 10yr DRIP, annual income (after tax)
$394,769,255.22/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SYANY beats the other by $394,760,926.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYANY + MRK for your $10,000?

SYANY: 50%MRK: 50%
100% MRK50/50100% SYANY
Portfolio after 10yr
$246.61M
Annual income
$232,222,108.02/yr
Blended yield
94.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SYANY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.3
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYANY buys
0
MRK buys
0
No recent congressional trades found for SYANY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYANYMRK
Forward yield3.11%2.76%
Annual dividend / share$0.50$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$493.15M$56.8K
Annual income after 10y$464,434,417.90$9,798.13
Total dividends collected$491.04M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SYANY vs MRK ($10,000, DRIP)

YearSYANY PortfolioSYANY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,321$621.33$11,206$366.19+$115.00SYANY
2$13,429$1,314.81$12,650$502.35+$779.00SYANY
3$17,284$2,915.03$14,407$694.19+$2.9KSYANY
4$25,506$7,012.83$16,585$967.82+$8.9KSYANY
5$46,636$19,344.25$19,342$1,363.89+$27.3KSYANY
6$116,011$66,110.67$22,913$1,947.19+$93.1KSYANY
7$431,527$307,394.53$27,662$2,823.89+$403.9KSYANY
8$2,598,957$2,137,223.14$34,159$4,173.35+$2.56MSYANY
9$26,840,438$24,059,554.97$43,337$6,308.80+$26.80MSYANY
10$493,153,687$464,434,417.90$56,776$9,798.13+$493.10MSYANY

SYANY vs MRK: Complete Analysis 2026

SYANYStock

Sydbank A/S, together with its subsidiaries, provides various banking products and services to corporate and retail customers in Denmark and internationally. The company operates in Banking, Asset Management, Sydbank Markets, Treasury, and Other segments. It offers various deposits, and loans and advances; and corporate banking services, including financing solutions and advisory services; and international commercial banking services, such as payment and cash management solutions. The company also provides private banking products and services, such as advice related to pensions, investments, and various financial issues; personal and individual advisory services; and payment card, insurance, and investment products and related services. In addition, it offers advisory and asset management services for investment funds, pooled pension plans, foundations, institutional clients, and wealthy customers; and advice and quotes prices as regards bonds, shares, and foreign exchange, as well as undertakes market-making obligations for institutional clients, central banks, asset managers, foreign and other clients, and banks. Further, the company is involved in macro, equity, and fixed income research activities. Additionally, it deals in mortgage bonds; and provides online solutions. As of December 31, 2021, the company operated through a network of 55 branches in Denmark and 3 branches in Germany. Sydbank A/S was founded in 1970 and is headquartered in Aabenraa, Denmark.

Full SYANY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SYANY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYANY vs SCHDSYANY vs JEPISYANY vs OSYANY vs KOSYANY vs MAINSYANY vs JNJSYANY vs ABBVSYANY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.